Cipla reports 26% rise in Q3 net profit

Cipla has reported results for third quarter ended December 31, 2012.

The company has reported 25.51% rise in its net profit at Rs 338.78 crore for the quarter as compared to Rs 269.91 crore for the same quarter in the previous year. Total income of the company has increased by 18.33% at Rs 2123.97 crore for quarter under review as compared to Rs 1794.95 crore for the quarter ended December 31, 2011.

Cipla focuses on development of new formulations and has a wide range of pharmaceutical products. It offers prescription drugs, bulk drugs, animal products and pesticides. It also offers a wide range of food and beverages, baked foods, oral hygiene products, detergents, room fresheners and personal care products.